These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34447292)

  • 1. Modern Technology in Multi-Shell Diffusion MRI Reveals Diffuse White Matter Changes in Young Adults With Relapsing-Remitting Multiple Sclerosis.
    Beaudoin AM; Rheault F; Theaud G; Laberge F; Whittingstall K; Lamontagne A; Descoteaux M
    Front Neurosci; 2021; 15():665017. PubMed ID: 34447292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-Retest Reliability of Diffusion Measures Extracted Along White Matter Language Fiber Bundles Using HARDI-Based Tractography.
    Boukadi M; Marcotte K; Bedetti C; Houde JC; Desautels A; Deslauriers-Gauthier S; Chapleau M; Boré A; Descoteaux M; Brambati SM
    Front Neurosci; 2018; 12():1055. PubMed ID: 30692910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic evaluation of intraoperative white matter tract shift in pediatric epilepsy surgery using high-field MRI and probabilistic high angular resolution diffusion imaging tractography.
    Yang JY; Beare R; Seal ML; Harvey AS; Anderson VA; Maixner WJ
    J Neurosurg Pediatr; 2017 May; 19(5):592-605. PubMed ID: 28304232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis.
    Jandric D; Parker GJM; Haroon H; Tomassini V; Muhlert N; Lipp I
    Neuroimage Clin; 2022; 34():102995. PubMed ID: 35349892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
    Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
    Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis.
    Chylińska M; Karaszewski B; Komendziński J; Wyszomirski A; Hałas M; Szurowska E; Sabisz A
    Neurol Sci; 2023 Sep; 44(9):3221-3232. PubMed ID: 37103603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibre-specific white matter changes in multiple sclerosis patients with optic neuritis.
    Gajamange S; Raffelt D; Dhollander T; Lui E; van der Walt A; Kilpatrick T; Fielding J; Connelly A; Kolbe S
    Neuroimage Clin; 2018; 17():60-68. PubMed ID: 29527473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosis.
    Andersen KW; Lasič S; Lundell H; Nilsson M; Topgaard D; Sellebjerg F; Szczepankiewicz F; Siebner HR; Blinkenberg M; Dyrby TB
    Brain Commun; 2020; 2(2):fcaa077. PubMed ID: 32954329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Analysis of Diffusion Tensor Imaging Along With Machine Learning Provides New Sensitive Measures of Tissue Pathology and Intra-Lesion Activity in Multiple Sclerosis.
    Oladosu O; Liu WQ; Pike BG; Koch M; Metz LM; Zhang Y
    Front Neurosci; 2021; 15():634063. PubMed ID: 34025338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
    Droby A; Fleischer V; Carnini M; Zimmermann H; Siffrin V; Gawehn J; Erb M; Hildebrandt A; Baier B; Zipp F
    Neuroimage Clin; 2015; 8():110-6. PubMed ID: 26106534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between white matter damage and gray matter lesions in multiple sclerosis patients.
    Han XM; Tian HJ; Han Z; Zhang C; Liu Y; Gu JB; Bakshi R; Cao X
    Neural Regen Res; 2017 May; 12(5):787-794. PubMed ID: 28616036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tract-specific MRI measures explain learning and recall differences in multiple sclerosis.
    Winter M; Tallantyre EC; Brice TAW; Robertson NP; Jones DK; Chamberland M
    Brain Commun; 2021; 3(2):fcab065. PubMed ID: 33959710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
    Asaf A; Evan S; Anat A
    Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
    Schiavi S; Petracca M; Sun P; Fleysher L; Cocozza S; El Mendili MM; Signori A; Babb JS; Podranski K; Song SK; Inglese M
    Brain; 2021 Feb; 144(1):213-223. PubMed ID: 33253366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Carotenuto A; Cacciaguerra L; Pagani E; Preziosa P; Filippi M; Rocca MA
    Brain; 2022 Aug; 145(8):2785-2795. PubMed ID: 34919648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.
    Hagiwara A; Kamagata K; Shimoji K; Yokoyama K; Andica C; Hori M; Fujita S; Maekawa T; Irie R; Akashi T; Wada A; Suzuki M; Abe O; Hattori N; Aoki S
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1642-1648. PubMed ID: 31515218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosis.
    Warlop NP; Achten E; Fieremans E; Debruyne J; Vingerhoets G
    Brain Cogn; 2009 Dec; 71(3):410-5. PubMed ID: 19576672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
    Wiebenga OT; Schoonheim MM; Hulst HE; Nagtegaal GJ; Strijbis EM; Steenwijk MD; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    AJNR Am J Neuroradiol; 2016 Jun; 37(6):1030-7. PubMed ID: 26965463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.